Literature DB >> 20418772

National program scale-up and patient outcomes in a pediatric antiretroviral treatment program, Thailand, 2000-2007.

Michelle S McConnell1, Sanchai Chasombat, Umaporn Siangphoe, Porntip Yuktanont, Rangsima Lolekha, Naparat Pattarapayoon, Surapol Kohreanudom, Philip A Mock, Kimberley Fox, Sombat Thanprasertsuk.   

Abstract

BACKGROUND: There are limited reports of public sector scale-up of antiretroviral treatment (ART) for HIV-infected children. We describe patient outcomes for HIV-infected children initiating ART in Thailand from 2000 to 2005.
METHODS: ART-naive patients <15 years old initiating ART from January 2000 to December 2005 were included; follow-up was through March 2007. Survival probabilities were estimated with Kaplan-Meier and hazard ratios for death and loss to follow-up (LTFU) with Cox proportional hazards models.
RESULTS: Analysis included 3409 children. Median follow-up time was 1.7 years (interquartile range = 1.0-2.5). Median age at ART initiation was 7.3 years, weight-for-age z score was -2.0, CD4% was 5.0%. ART was initiated in 1428 (41.9%) children at regional/university hospitals and in 689 (20.2%) at district/community hospitals. At last visit, 346 (10.1%) were LTFU and 305 (9.0%) had died. Age <1 (P = 0.008), weight-for-age z score <-2.0 (P < 0.001), CD4% <5% (P < 0.001), and clinical stage C (P < 0.001) were associated with death; district/community hospital patients had a lower hazard of death (P = 0.011). Clinical stage C (P = 0.052) and regional/university hospital (P < 0.001) were associated with increased LTFU.
CONCLUSIONS: Pediatric ART has been successfully scaled-up in Thailand, including to district/community hospitals. Late entry to care is associated with poorer outcomes, and earlier ART initiation should be prioritized.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20418772     DOI: 10.1097/QAI.0b013e3181dc5eb0

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  14 in total

1.  Vertically transmitted HIV infection having first clinical manifestations at 13 y of age.

Authors:  Amitabh Sagar; Biju Vasudevan
Journal:  Indian J Pediatr       Date:  2011-12-29       Impact factor: 1.967

2.  Mortality and loss to follow-up in the first year of ART: Malawi national ART programme.

Authors:  Ralf Weigel; Janne Estill; Matthias Egger; Anthony D Harries; Simon Makombe; Hannock Tweya; Andreas Jahn; Olivia Keiser
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

3.  Decentralization of pediatric HIV care and treatment in five sub-Saharan African countries.

Authors:  Ruby N Fayorsey; Suzue Saito; Rosalind J Carter; Eduarda Gusmao; Koen Frederix; Emily Koech-Keter; Gilbert Tene; Milembe Panya; Elaine J Abrams
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

4.  Mortality and treatment outcomes of China's National Pediatric antiretroviral therapy program.

Authors:  Yan Zhao; Chunming Li; Xin Sun; Weiwei Mu; Jennifer M McGoogan; Yun He; Yuewu Cheng; Zhirong Tang; Huiqin Li; Mingjian Ni; Ye Ma; Ray Y Chen; Zhongfu Liu; Fujie Zhang
Journal:  Clin Infect Dis       Date:  2012-11-21       Impact factor: 9.079

5.  Five-year trends in antiretroviral usage and drug costs in HIV-infected children in Thailand.

Authors:  Intira Collins; John Cairns; Sophie Le Coeur; Karin Pagdi; Chaiwat Ngampiyaskul; Prapaisri Layangool; Thitiporn Borkird; Sathaporn Na-Rajsima; Vanichaya Wanchaitanawong; Gonzague Jourdain; Marc Lallemant
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

6.  Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa.

Authors:  Ashraf Grimwood; Geoffrey Fatti; Eula Mothibi; Mokgadi Malahlela; Jawaya Shea; Brian Eley
Journal:  J Int AIDS Soc       Date:  2012-05-31       Impact factor: 5.396

7.  The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study.

Authors:  Andrew Edmonds; Marcel Yotebieng; Jean Lusiama; Yori Matumona; Faustin Kitetele; Sonia Napravnik; Stephen R Cole; Annelies Van Rie; Frieda Behets
Journal:  PLoS Med       Date:  2011-06-14       Impact factor: 11.069

Review 8.  The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.

Authors:  Annette H Sohn; Rohan Hazra
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

9.  Successful clinical outcomes following decentralization of tertiary paediatric HIV care to a community-based paediatric antiretroviral treatment network, Chiangrai, Thailand, 2002 to 2008.

Authors:  Rawiwan Hansudewechakul; Thananda Naiwatanakul; Abraham Katana; Worawan Faikratok; Rangsima Lolekha; Vorapathu Thainuea; Michelle S McConnell
Journal:  J Int AIDS Soc       Date:  2012-10-11       Impact factor: 5.396

Review 10.  Immediate antiretroviral therapy in young HIV-infected children: benefits and risks.

Authors:  Intira J Collins; Ali Judd; Diana M Gibb
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.